![FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product](https://cdn.newsserve.net/ONPglobe256.png)
FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product
Today, the U.S. Food and Drug Administration approved RiVive, 3 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use for the emergency treatment of known or suspected opioid overdose. This is the second nonprescription naloxone product the agency has…
#rivive #fda #robertmcaliff